Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

diaDexus licenses rights to testisin cancer target

Feb. 14, 2003

Debiopharm forms collaboration with Tulane University

Feb. 13, 2003

Lorus Therapeutics and NCI to evaluate GTI-2040 in phase II trials

Feb. 13, 2003

Echelon Biosciences awarded grant for cancer and diabetes research

Feb. 13, 2003

Aventis claims new KDR inhibitors obtained from natural source

Feb. 13, 2003

SuperGen submits second module of rolling NDA for Orathecin

Feb. 12, 2003

AstraZeneca submits MAA for Iressa for advanced NSCLC

Feb. 12, 2003

Transgene announces encouraging results from phase I oncology trials

Feb. 12, 2003

Clinical toxicity and pharmacokinetics determined for lead alkycycline

Feb. 11, 2003

Fludara receives E.U. approval as first-line treatment for B-CLL

Feb. 11, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...